Related Experiment Videos
Setting cutoff concentrations for immunoassay screening of postmortem blood
I B Collison1, V R Spiehler, S Guluzian
1Forensic Science Services, Santa Ana, CA, USA.
Journal of Forensic Sciences
|April 17, 1998
Summary
This study optimized cutoff concentrations for drug abuse screening in postmortem blood using coated tube radioimmunoassay (RIA). The new RIA method demonstrated comparable or superior accuracy to the previous double antibody RIA for detecting opiates, amphetamines, cocaine, and barbiturates.
Area of Science:
- Forensic Toxicology
- Analytical Chemistry
- Immunoassay Development
Background:
- Accurate drug abuse screening in postmortem toxicology is crucial for coroner's cases.
- Previous methods relied on double antibody radioimmunoassay (RIA), necessitating evaluation of newer techniques.
- Optimizing immunoassay cutoffs is key to ensuring reliable screening results.
Purpose of the Study:
- To establish optimal immunoassay cutoff concentrations for a coated tube RIA.
- To ensure the coated tube RIA performs equally to or better than the double antibody RIA.
- To validate screening results against GC/MS confirmation.
Main Methods:
- Evaluated 4-7 cutoff concentrations for opiates, amphetamines, cocaine, and barbiturates.
- Utilized 350 postmortem blood and liver homogenate specimens.
- Compared coated tube RIA results with GC/MS and GLC (NPD/FID) confirmed results.
Main Results:
- Selected cutoffs: 5 ng/mL morphine, 25 ng/mL methamphetamine, 500 ng/mL benzoylecgonine, 500 ng/mL secobarbital.
- Achieved high sensitivity and specificity for the coated tube RIA across drug classes.
- Demonstrated comparable or superior performance to the double antibody RIA for most drug classes.
Conclusions:
- The established cutoffs for the coated tube RIA provide reliable screening for drugs of abuse in postmortem samples.
- The coated tube RIA is a viable alternative to double antibody RIA for forensic toxicology screening.
- Optimized cutoffs enhance the accuracy and efficiency of postmortem drug testing.